The pre-operative evaluation of commonly used serum tumour markers, such as CEA, CA19-9, CA-125, and AFP, is very important for the treatment planning of patients with CRC, because their levels have been associated with the prognosis of CRC patients [35]. The gene discussed is AFP; the disease is colorectal carcinoma.